Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Defence Therapeutics (DTCFF)
OTHER OTC:DTCFF
Defence Therapeutics (DTCFF) Ownership - Who Owns Defence Therapeutics?
9 Followers
Defence Therapeutics (DTCFF) Ownership Overview
1.66% Insiders
0.00% Mutual Funds
0.00% Other Institutional Investors
98.34% Public Companies and
Individual Investors
The ownership structure of Defence Therapeutics (DTCFF) stock is a mix of institutional, retail and individual investors. Approximately 0.00% of the company’s stock is owned by Institutional Investors, 1.66% is owned by Insiders and 98.34% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Jun 11, 2024 | Partick Joseph Meagher Chief Financial Officer | Bought | C$2850 |
| May 31, 2024 | Partick Joseph Meagher Chief Financial Officer | Bought | C$7662 |
| May 24, 2024 | Daniel Kwin Grauer Non Executive,director | Bought | C$10625 |
| Dec 14, 2023 | Sarkis Meterissian Non Executive,director | Sold | C$16500 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 379,100 | Insider | 0.83% | 227,460 | |
| 192,000 | Insider | 0.42% | 115,200 | |
| 116,000 | Insider | 0.25% | 69,600 | |
| 50,000 | Insider | 0.11% | 30,000 | |
| 18,500 | Insider | 0.04% | 11,100 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Defence Therapeutics (DTCFF)?
According to the latest TipRanks data, approximately 0.00% of the company's stock is held by institutional investors, 1.66% is held by insiders, and 98.34% is held by retail investors.
What percentage of Defence Therapeutics (DTCFF) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.00% of Defence Therapeutics (DTCFF) stock is held by institutional investors.
What percentage of Defence Therapeutics (DTCFF) stock is held by retail investors?
According to the latest TipRanks data, approximately 98.34% of Defence Therapeutics (DTCFF) stock is held by retail investors.
Who owns the most shares of Defence Therapeutics (DTCFF)?
Partick Joseph Meagher owns the most shares of Defence Therapeutics (DTCFF).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.